Raymond March, Ph.D.

Affiliated Scholar

Bio

Raymond March is an affiliate scholar at the Challey Institute for Global Innovation and Growth. His research examines the public and private provision and governance of health care in the United States, particularly in pharmaceutical markets. His research has appeared in Southern Economic JournalPublic ChoiceResearch PolicyJournal of Institutional Economics, and other academic publications. He co-edited the 2022 book Pandemics and Liberty. Dr. March is a research fellow at the Independent Institute and director of FDAReview.org, an educational research and communications project on the U.S. Food and Drug Administration (FDA). He regularly blogs on health policy at The Beacon and the American Institute for Economic Research.

Education
  • Ph.D., Agricultural and Applied Economics, Texas Tech University
  • M.A., Agricultural and Applied Economics, Texas Tech University
  • B.S., Economics and Business Management, Florida Gulf Coast University
Recent Media
The Beacon | COVID-19 Vaccines and the Ratchet Effect: Lessons from Crisis and Leviathan
The Beacon | Supply, Demand, and Wegovy
WalletHub | Low Interest Credit Cards
The Beacon | If the FDA Wants People to Stop Smoking, it Should Stop Meddling in the Vaping Market
WalletHub | Rental Car Insurance: Key Things to Know in 2024
The Beacon | What Would Kamala Harris's FDA Look Like?
Catalyst | Bootleggers, Baptists, and Vaping: The high costs of paternalism in public health
The Beacon | The Controversy Surrounding Microdosing Chocolate Bars: What is the Future of Psilocybin in Medicine
MoneyGeek | Common Health Insurance Scams & How to Avoid Them
MoneyGeek | Guide to Obtaining Insurance for Mental Health Care
WalletHub | Rental Car Insurance
Blog | The FDA Is Coming After Microdosing Chocolate Bars
Blog | Why Are So Many Food and Beverage Products Bing Recalled? 
Op-Ed | Thank Walmart, Not Biden or Trump, for Lower Insulin Prices
Blog | The Beacon | The FDA Is Not a Referee
Blog | The Beacon | Will the Blundering FDA Receive More Power? 
Blog | The Beacon | DEA and FDA Duke it Out Over Marijuana Scheduling
Blog | The Beacon | You Can't Spend Your Way Out of an Opioid Crisis
MoneyGeek | The Best and Worst States for Health Care
MoneyGeek | Experts' Insights About Understanding Health Care
WalletHub | 10 Best Credit Cards of April 2024
Blog | Independent Institute | Did Healthcare Spending Really Return to Pre-Pandemic Levels?
Blog | Independent Institute | Another Infant Formula Shortage? Blame the FDA
Article | NPR | These Are Some Christmas Traditions Around the World, From Fistfights to KFC
Op-Ed | The Hill | Political Promises Won't End Drug Shortages
Blog | Independent Institute | Gene Therapy: A Promising Medical Frontier Hindered by Regulatory Roadblocks
Blog | Independent Institute | Who Should Decide if Weight-Loss Injections Should be Prescribed for Kids? 
Blog | Independent Institute | More Oversight Won't Help the US Baby Formula Market
Blog | Independent Institute | The FDA Should Stay Away from Laboratory Developed Tests
AIER | Psychedelics Will Help America's Mental Health Crisis - If the FDA Lets Them
DC Journal | Decongestant Drug Doesn't Work? Neither Does the FDA
MoneyGeek | Expert Advise on Best Health Insurance Option When Unemployed
Blog | Independent Institute | The Pandemic is Over, But Pandemic Policies Are Not
Blog | Catalyst | The Mental Health Crisis and FDA Hurdles
Blog | Independent Institute | FDA Efforts to Curb Youth Vaping Continue to Come Up Short
Blog | Independent Institute | The FDA Loosens Blood Donation Restrictions, Finally
Blog | Independent Institute | Recent Attacks on Recreational Marijuana Legalization Are All Smoke
WalletHub | Average Car Insurance Cost
MoneyGeek | Expert Advice on Most Affordable Health Insurance In North Dakota
MoneyGeek | Expert Advice: Health Insurance Costs
MoneyGeek | Expert Advice: Finding the Best Health Insurance
Blog | Independent Institute | FDA's Rare Positive Move
Blog | Independent Institute | Insulin Price-Caps: A Solution or a Recipe for Rationing?
Blog | Independent Institute | Are Insulin Prices About to Drop? The Devil is in the Details
Blog | Independent Institute | When is a Drug Safe and Effective Enough? 
Blog | Independent Institute | The FDA is Too Little Too Late in Tinkering with COVID-19 Booster Schedules
Blog | Independent Institute | Deregulation Remains Our Best Hope to Combat Alzheimer's Disease
Edited Volume | Pandemics and Liberty
Blog Contributor | Independent Institute
Blog Contributor | American Institute for Economic Research
AIER | Pandemics and Liberty: An Introduction
WebMD | Could Pot Prevent a Pot Belly? Researchers Get the Skinny on Cannabis
Stranded Technologies Podcast | The Case Against the FDA
Fortune | The FDA Could Easily Solve the Baby Formula Shortage by Allowing More Imports from Europe
The Forum of Fargo-Moorhead | Competition, Not More Regulation, is Needed to Lower Insulin Costs

 

Top of page